2022
DOI: 10.1186/s13287-021-02694-y
|View full text |Cite
|
Sign up to set email alerts
|

Optimization of human umbilical cord blood-derived mesenchymal stem cell isolation and culture methods in serum- and xeno-free conditions

Abstract: Background Although umbilical cord blood (UCB) is identified as a source of mesenchymal stem cells (MSCs) with various advantages, the success in cell isolation is volatile. Therefore, it is necessary to optimize methods of cord blood-derived MSC (UCB-MSC) isolation and culture. In this study, we evaluated the efficiency of UCB-MSC isolation and expansion using different commercially available serum- and xeno-free media and investigated the capacity of autologous serum and plasma as a supplemen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(18 citation statements)
references
References 48 publications
0
18
0
Order By: Relevance
“…Ideally, the culture medium in the whole process of cell sheet manufacture, including cell culture, should be chemically defined and not contain animal extracts, research-grade human extracts, or research-grade exogenous growth factors. Although several serum-free media have been investigated for human mesenchymal stem cell (MSC) expansion [ 21 , 22 , 23 , 24 ], ingredients of these mediums could not be risk-evaluated and controlled in final products due to their confidentiality, which does not meet the GMP guidelines and drug standards. In addition, these media contain a variety of research-grade exogenous growth factors or human/animal extracts, which would also cause safety risks for clinical applications.…”
Section: Discussionmentioning
confidence: 99%
“…Ideally, the culture medium in the whole process of cell sheet manufacture, including cell culture, should be chemically defined and not contain animal extracts, research-grade human extracts, or research-grade exogenous growth factors. Although several serum-free media have been investigated for human mesenchymal stem cell (MSC) expansion [ 21 , 22 , 23 , 24 ], ingredients of these mediums could not be risk-evaluated and controlled in final products due to their confidentiality, which does not meet the GMP guidelines and drug standards. In addition, these media contain a variety of research-grade exogenous growth factors or human/animal extracts, which would also cause safety risks for clinical applications.…”
Section: Discussionmentioning
confidence: 99%
“…The immunophenotypes of MSCs make it possible to be transplanted in an autologous or an allogeneic way, which broadens clinical applications. However, there are differences in the surface markers of MSCs due to the MSC sources [12], donor age [13], isolation methods [14], and culture conditions [15]. In vitro, MSCs of different origins differ in their ability to expand.…”
Section: Main Resources Of Mscsmentioning
confidence: 99%
“…Due to the low recovery of MSCs circulate in UCB, it is difficult to isolate and culture them compared to haematopoietic stem cells. Besides that, the yield is also inversely affected by gestation age ( 38 ). UCB-MSCs also underwent senescence earlier than other PL-MSCs.…”
Section: Introductionmentioning
confidence: 99%
“…One of the major setbacks contributing to the wide-ranging success rate between 10% and 90% in culturing UCB-MSCs is inconsistency in the isolation process ( 38 , 42 ). Many researchers have collectively shown that sample volume, cellular content and processing duration after CB collection play an important role in determining the success rate ( 42 , 43 ).…”
Section: Introductionmentioning
confidence: 99%